JDRF Blog

Latest in Glucose control

  • Nation’s Largest Insurer Expands Insulin Pump Coverage

    July 1, 2020

    In a victory for JDRF’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their diabetes.

  • The Importance of Dexcom CLARITY: From Telemedicine to Ultra Marathons

    June 17, 2020

    Elite T1D Athlete Eric Tozer and Dexcom Certified Diabetes Educator (CDE) Cher Pastore discuss Dexcom CLARITY technology.

  • Severe Hypoglycemia: Be Prepared, not Afraid

    June 17, 2020

    Fear of Hypoglycemia is a real thing. Learn how you and your loved ones with T1D can overcome it.

  • FreeStyle Libre 2 Authorized for Use in the U.S.

    June 15, 2020

    On June 15, 2020, Abbott announced that the FDA has authorized the FreeStyle Libre 2 System. The Libre 2 gained its CE...

  • ADA’s Scientific Sessions: Day 3

    June 15, 2020

    The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta...

  • Medtronic Panel Discusses Supporting T1D Community During COVID-19

    May 14, 2020

    During a recent JDRF Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community during the pandemic.

  • A Potential First-in-Class Adjunct Therapy in Type 1 Diabetes

    March 19, 2020

    Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes Association. Despite...

  • JDRF and Gore Invest in Development of Implantable Insulin Delivery System

    January 22, 2020

    PhysioLogic Devices, a JDRF-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to develop the ThinPump™—a...

  • FDA Grants Breakthrough Device Status: iLet Bionic Pancreas

    December 23, 2019

    Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the company’s iLet...